Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Macrae

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
The British Journal of Surgery|December 1, 1983
Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasmsA J Silman, P Mitchell, R J Nicholls, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2018
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study)A B Friedman, S J Brown, P Bampton, et al.
Clinical Genetics|September 29, 2012
Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expressionM Clendenning, F A Macrae, M D Walsh, et al.
British Journal of Cancer|May 12, 2011
Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genesA K Win, J G Dowty, D R English, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2015
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisP De Cruz, M A Kamm, A L Hamilton, et al.
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
The British Journal of Surgery|December 1, 1983
Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasmsA J Silman, P Mitchell, R J Nicholls, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2018
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study)A B Friedman, S J Brown, P Bampton, et al.
Clinical Genetics|September 29, 2012
Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expressionM Clendenning, F A Macrae, M D Walsh, et al.
British Journal of Cancer|May 12, 2011
Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genesA K Win, J G Dowty, D R English, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2015
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisP De Cruz, M A Kamm, A L Hamilton, et al.
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
Pageof 6